Copyright
©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 5979-5984
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5979
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5979
Table 1 Doses and treatment schedules for each level
| Gemcitabine | Cisplatin | S-1 (mg/d, Days 1-7, 15-21) | |||
| (mg/m2, Days 1, 15) | BSA < 1.25 | 1.25 < BSA < 1.5 | BSA > 1.5 | ||
| Level -1 | 800 | 20 | 60 | 80 | 100 |
| Level 0 | 800 | 25 | 60 | 80 | 100 |
| Level 1 | 1000 | 25 | 60 | 80 | 100 |
| Level 2 | 1000 | 25 | 80 | 100 | 120 |
- Citation: Watanabe A, Kida M, Miyazawa S, Iwai T, Okuwaki K, Kaneko T, Yamauchi H, Takezawa M, Imaizumi H, Koizumi W. Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. World J Gastroenterol 2015; 21(19): 5979-5984
- URL: https://www.wjgnet.com/1007-9327/full/v21/i19/5979.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i19.5979